ChiCTR2100047396 版本V1.5 版本创建时间2022/01/05 15:04:00 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100047396 

最近更新日期:

Date of Last Refreshed on:

2022-01-04 12:14:50 

注册时间:

Date of Registration:

2021-06-16 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

会阴裂伤风险预测模型的构建研究

Public title:

Research on the construction of risk prediction model of perineal laceration

注册题目简写:

English Acronym:

研究课题的正式科学名称:

会阴裂伤风险预测模型的构建研究

Scientific title:

Research on the construction of risk prediction model of perineal laceration

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张涵 

研究负责人:

张涵 

Applicant:

Zhang Han 

Study leader:

Zhang Han 

申请注册联系人电话:

Applicant telephone:

+86 13122366078

研究负责人电话:

Study leader's
telephone:

+86 13122366078

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

hannahzhang18@163.com

研究负责人电子邮件:

Study leader's E-mail:

hannahzhang18@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

同济大学附属第一妇婴保健院

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市浦东新区高科西路2699号

研究负责人通讯地址:

上海市浦东新区高科西路2699号

Applicant address:

2699 Gaoke Road West, Pudong New Area, Shanghai

Study leader's address:

2699 Gaoke Road West, Pudong New Area, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

201204

研究负责人邮政编码:

Study leader's postcode:

201204

申请人所在单位:

同济大学附属第一妇婴保健院

Applicant's institution:

Shanghai First Maternity and Infant Hospital, Tongji University

研究负责人所在单位:

同济大学附属第一妇婴保健院

Affiliation of the Leader:

Shanghai First Maternity and Infant Hospital, Tongji University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KS21215

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市第一妇婴保健院伦理委员会

Name of the ethic committee:

Shanghai First Maternal and Infant Hospital Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2021-04-21 00:00:00

伦理委员会联系人:

罗烨

Contact Name of the ethic committee:

Luo Ye

伦理委员会联系地址:

上海市浦东新区高科西路2699号

Contact Address of the ethic committee:

2699 Gaoke Road West, Pudong New Area, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

同济大学附属第一妇婴保健院

Primary sponsor:

Shanghai First Maternity and Infant Hospital, Tongji University

研究实施负责(组长)单位地址:

上海市浦东新区高科西路2699号

Primary sponsor's address:

2699 Gaoke Road West, Pudong New Area, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

浦东新区

Country:

China

Province:

Shanghai

City:

Pudong New Area

单位(医院):

同济大学附属第一妇婴保健院

具体地址:

高科西路2699号

Institution
hospital:

Shanghai First Maternity and Infant Hospital, Tongji University

Address:

2699 Gaoke Road West

经费或物资来源:

上海申康医院发展中心项目专项基金

Source(s) of funding:

Shanghai Shenkang Hospital Development Center Project Special Fund

研究疾病:

会阴裂伤  

Target disease:

perineal laceration

研究疾病代码:

Target disease code:

研究类型:

筛查

Study type:

Screening

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

本研究立足于我国国情,拟揭示影响我国经阴道分娩女性发生会阴裂伤的特异性因素,构建会阴裂伤风险预测模型,为后期有效进行早发现、早干预、早治疗的集束化管理奠定理论基础。  

Objectives of Study:

Based on the national conditions of China, this study intends to reveal the specific factors affecting the occurrence of perineal laceration in Chinese women after vaginal delivery, and build a risk prediction model for perineal laceration, so as to lay a theoretical foundation for the cluster management of early detection, early intervention and early treatment in the later stage.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.在上海市第一妇婴保健院产科病房拟行阴道分娩的待产产妇;
2.了解本研究的方法和目的,可独立进行问卷填写,并签署知情同意书。

Inclusion criteria

1.The expectant parturient in the obstetric ward of Shanghai First Maternity and Infant Hospital who planned to undergo vaginal delivery;
2.Understand the method and purpose of this study, can fill in the questionnaire independently, and sign the informed consent.

排除标准:

1.伴有精神、意识、认知障碍及(或)合并其他严重躯体疾病的孕产妇;
2.前期会阴裂伤还未修复的产妇;
3.最终行剖宫产或由阴道分娩转剖宫产的产妇;
4.不予以配合或主动要求退出的产妇;
5.分娩资料不全的产妇。

Exclusion criteria:

1.Pregnant and parturient women with mental, conscious, cognitive disorders and/or other serious physical diseases;
2.Prophase perineal laceration has not been repaired parturient;
3.Parturient women undergoing cesarean section or transferring from vaginal delivery to cesarean section;
4.Pregnant women who do not cooperate or voluntarily request withdrawal;
5.Parturient women with incomplete childbirth information.

研究实施时间:

Study execute time:

From 2020-10-01 00:00:00 To 2022-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-07-01 00:00:00 To 2022-01-31 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

420

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

浦东新区 

Country:

China

Province:

Shanghai

City:

Pudong New Area

单位(医院):

同济大学附属第一妇婴保健院 

单位级别:

三级甲等 

Institution
hospital:

Shanghai First Maternity and Infant Hospital, Tongji University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

会阴裂伤分级

指标类型:

主要指标

Outcome:

Classification of perineal laceration

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

妊娠结局

指标类型:

次要指标

Outcome:

Pregnancy outcome

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

本研究为观察性研究,采取方便抽样方法。

Randomization Procedure (please state who generates the random number sequence and by what method):

This study is an observational study and convenient sampling method is adopted.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

中国临床试验中心 http://www.chictr.org.cn。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

China Clinical Trial Center http://www.chictr.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

产前通过问卷调研采集数据,产后通过查阅电子病历系统采集分娩相关资料。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data will be collected by questionnaire survey before birth, and delivery data will be collected by referring to electronic medical record system after birth.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-06-16 20:39:54